No Data
DXC Technology Issues Weak Outlook, Joins Take-Two Interactive And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 10 points on Friday.Shares of DXC Technology Company (NYSE:DXC) fell sharply in today's pre-market trading afte
Nayax Posts Weak Q1 Results, Joins GameStop, Iris Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Thursday.Shares of Nayax Ltd. (NASDAQ:NYAX) fell sharply in today's pre-market trading following weak
Ocugen Is Maintained at Buy by Chardan Capital
Ocugen Is Maintained at Buy by Chardan Capital
Ocugen Price Target Maintained With a $5.00/Share by Chardan Capital
Ocugen Price Target Maintained With a $5.00/Share by Chardan Capital
Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study
Ocugen (OCGN) said Wednesday it has completed dosing of the second group of its phase 1/2 clinical study of its experimental gene modifier therapy candidate OCU41OST, being developed as a one-time tre
HC Wainwright & Co. : The Ocugen (OCGN.US) rating was reaffirmed and adjusted from buy to buy, and the target price was $7.00.
HC Wainwright & Co. : The Ocugen (OCGN.US) rating was reaffirmed and adjusted from buy to buy, and the target price was $7.00.